REQUEST A DEMO
Total
USD $0.00
Search more companies

Thea Pharma Ilac Ticaret Ltd. Sti. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Thea Pharma Ilac Ticaret Limited Sirketi Profile Updated: May 07, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

théa pharma is an independent pharmaceutical company specializing in ophthalmology. The company offers a complete portfolio of preservative and therapeutic products for eye health, including innovative molecules and application tools. théa pharma is a manufacturer of preservative eye drops and claims to have a strong presence in Europe, North Africa, and South America. The company is committed to research and innovation in ophthalmology, with a focus on developing new treatments and improving existing therapies.

Headquarters
D:21 No:10n Dikilitas Mahallesi Hakki Yeten Caddesi Besiktas
Istanbul; Marmara; Postal Code: 34349

Contact Details: Purchase the Thea Pharma Ilac Ticaret Ltd. Sti. report to view the information.

Website: http://www.theapharma.com.tr

Basic Information
Total Employees:
Purchase the Thea Pharma Ilac Ticaret Ltd. Sti. report to view the information.
Outstanding Shares:
Purchase the Thea Pharma Ilac Ticaret Ltd. Sti. report to view the information.
Incorporation Date:
April 06, 2011
Key Executives
Purchase this report to view the information.
Company Manager
Company Performance
Financial values in the chart are available after Thea Pharma Ilac Ticaret Ltd. Sti. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
39.61%
Total operating revenue
39.61%
Operating profit (EBIT)
30.04%
Net Profit (Loss) for the Period
39.88%
Total assets
32.79%
Total equity
28.24%
Operating Profit Margin (ROS)
-0.64%
Net Profit Margin
0.01%
Return on Equity (ROE)
1.8%
Quick Ratio
0.28%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?